Vipshop Holdings Ltd - ADR (VIPS) Stock Price Today
Workday launches AI research team with new innovations amid mixed analyst ratings.
Workday has established a dedicated AI Research team to develop advanced, reliable AI solutions for enterprises, achieving notable improvements in AI memory precision and task accuracy. The company also introduced a PhD Fellowship program to support ...
Barclays keeps 'Underweight' on Target despite raising price target to $140 amid strong Q2 results.
Barclays maintained an "Underweight" rating on Target's stock but raised its price target from $115 to $140, even though Target's shares trade above $161. This cautious stance reflects concerns that Target may underperform its peers despite a strong ...
Sea Limited director sells 20,000 shares worth $2.4 million
Heng Chen Seng, a director at Sea Limited, sold 20,000 shares valued at $2.4 million. This insider sale may indicate personal portfolio adjustments but does not necessarily reflect company performance. Investors should monitor further insider activit...
Moderna shares soar over 160% after positive Phase 3 melanoma vaccine trial results
Moderna and Merck announced successful Phase 3 trial results for their personalized mRNA melanoma vaccine combined with Keytruda, showing significant improvement in recurrence-free and distant metastasis-free survival. This marks the first positive l...
Ark Invest buys $27M Nvidia and $16M Broadcom amid market sell-off, signaling potential buying opportunity.
During the recent market sell-off, Cathie Wood's Ark Invest purchased $27 million worth of Nvidia shares and $16 million of Broadcom shares. These significant buys by a well-known investor suggest confidence in these tech stocks despite broader marke...
Merck leads 2026 pharma stocks with 44% gain, outpacing Amgen and Pfizer despite no obesity drug franchise.
In 2026, Merck's stock surged 44% year-to-date, outperforming major U.S. drugmakers Amgen (up 35%) and Pfizer (up 14%). Merck's success is driven by its strong oncology portfolio, including the top-selling cancer drug KEYTRUDA, and diverse products b...
VivoPower retires $28.8M debt, boosts credit ahead of Norway AI data center project
VivoPower PLC has fully retired $28.8 million in shareholder debt owed to AWN Holdings, improving its credit profile as it prepares to build an AI data center in Mo i Rana, Norway. The debt retirement removes interest expenses and follows a $50 milli...
Industrial machinery stocks surge on electrification and data center demand in 2026
In 2026, industrial machinery stocks like GE Vernova, Eaton, and Cummins have surged due to strong demand for electrification and data center power solutions. GE Vernova leads with a 50% gain, driven by record revenue, orders, and raised guidance fue...
US DOE selects American Tungsten's subsidiary for up to $18M funding to boost antimony smelting capacity
American Tungsten & Antimony's US subsidiary, Trigg Minerals, has been chosen by the U.S. Department of Energy to negotiate a potential financial award of up to $18 million. This funding is part of a $162 million DOE program aimed at expanding critic...
Walmart downgraded amid e-commerce challenges ahead of Q2 earnings report
Walmart faces increased competition from Amazon in higher-margin retail categories despite leading U.S. grocery spending. Oppenheimer downgraded Walmart from "Outperform" to "Perform" and removed its $140 price target, citing risks including pharmacy...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.